While other MediaPost newsletters and articles remain free to all ... our new Research Intelligencer service is reserved for paid subscribers ...
Subscribe today to gain access to every Research Intelligencer article we publish as well as the exclusive daily newsletter, full access to The MediaPost Cases, first-look research and daily insights from Joe Mandese, Editor in Chief.
Become a free MediaPost member now to read this article
Unlimited articles every day
Keep up-to-date with media, marketing and advertising news
Invitations to exclusive industry events and research
Subscribe to MediaDailyNews
Report: Carat Out Of J&J Review
November 27, 2006
Carat is out of the review for Johnson & Johnson's $400 million-plus media buying and planning consolidation, reports Advertising Age. Carat, which handles Pfizer, became a J&J roster agency
when J&J acquired some Pfizer brands.
